Jushi Holdings (JUSHF) Non Operating Income (2021 - 2026)
Jushi Holdings (JUSHF) reported Non Operating Income of -$12.7 million for Q1 2026, down 106.18% year-over-year from $205.7 million in Q1 2025, and up 72.03% quarter-over-quarter from -$45.4 million in Q4 2025.
Jushi Holdings (JUSHF) Non Operating Income (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Non Operating Income data on file, last reported at -$12.7 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$12.7 million, down 106.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$64.8 million (down 581.2% YoY), and the FY2025 annual result was -$38.5 million, down 1324.65% from the prior year.
- Non Operating Income climbed to -$12.7 million in Q1 2026 per JUSHF's latest filing, from -$45.4 million in the prior quarter.
- Over five years, Non Operating Income peaked at $24.1 million in Q4 2024 and troughed at -$45.4 million in Q4 2025.
- A 5-year average of -$7.0 million and a median of -$6.0 million in 2025 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 174.5% in 2024 and fell as far as 5911.42% in 2024.
- A 5-year view of Non Operating Income shows it stood at -$2.2 million in 2022, then slumped by 1344.22% to -$32.4 million in 2023, then soared by 174.5% to $24.1 million in 2024, then tumbled by 288.49% to -$45.4 million in 2025, then jumped by 72.03% to -$12.7 million in 2026.
- Business Quant data shows JUSHF's Non Operating Income at -$12.7 million in Q1 2026, -$45.4 million in Q4 2025, and -$606000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | -12.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.71 Mn |
| Dec 31, 2025 | -45.45 Mn |
| Sep 30, 2025 | -606,000.00 |
| Jun 30, 2025 | -6.01 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | 24.11 Mn |
| Sep 30, 2024 | -7.23 Mn |
| Jun 30, 2024 | 2.75 Mn |
| Mar 31, 2024 | -12.73 Mn |
| Dec 31, 2023 | -32.37 Mn |
| Sep 30, 2023 | -15.44 Mn |
| Jun 30, 2023 | -8.89 Mn |
| Mar 31, 2023 | 219,000.00 |
| Dec 31, 2022 | -2.24 Mn |
| Sep 30, 2022 | -291,000.00 |
| Jun 30, 2022 | 228,000.00 |
| Mar 31, 2022 | 3.49 Mn |
| Dec 31, 2021 | 86.51 Mn |
| Sep 30, 2021 | 47.84 Mn |
| Jun 30, 2021 | 13.74 Mn |